pharma mergers and acquisitions
Novartis invests further $15m into Gamida Cell
October 13, 2015Research and Development, Sales and Marketing Gamida Cell, Novartis, pharma mergers and acquisitions
Novartis is to invest an extra $15 million into Israeli stem cell therapy developer Gamida Cell, adding an additional 2.5% …
Horizon Pharma receives third rejection from Depomed
August 21, 2015Sales and Marketing Depomed, Horizon Pharma, pharma mergers and acquisitions
Depomed has announced that its board has unanimously rejected Horizon Pharma’s third proposal to buy the California-based company. Following its …
Teva to switch generics focus to Allergan
July 27, 2015Sales and Marketing Allergan, Teva, generics, mergers and acquisitions, pharma mergers and acquisitions
Teva is in negotiations to buy Allergan’s generics division for upwards of $40 billion, according to reports. The generics firm …
Elliott maintains pressure on Actelion
April 15, 2011Sales and Marketing Actelion, pharma mergers and acquisitions
Investment firm Elliott Advisors is maintaining its push for a new leadership team at Actelion.The investment firm is the biggest …
Sanofi ‘considering’ raising Genzyme offer
January 19, 2011Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, pharma mergers and acquisitions
Sanofi-Aventis could be willing to raise its offer to $76 a share to buy the US biotech firm Genzyme, according …
